08/30/2024 3:04 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:40 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 3:31 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:24 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024 3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2024 4:15 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
05/09/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 8:27 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 8:32 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:55 PM | Vera Therapeutics (Filer)
| Form ARS | |
04/03/2024 4:00 PM | Vera Therapeutics (Filer)
| Form DEF 14A | |
04/03/2024 4:02 PM | Vera Therapeutics (Filer)
| Form DEFA14A | |
03/26/2024 7:35 PM | Vera Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:57 PM | Sofinnova Venture Partners X, L.P. (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
03/25/2024 8:46 PM | Katabi Maha (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:54 PM | Katabi Maha (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 6:11 PM | Sofinnova Venture Partners X, L.P. (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/14/2024 3:57 PM | CITADEL ADVISORS LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 2:21 PM | Ares Trading S.A. (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 11:49 AM | Kynam Capital Management, LP (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024 3:45 PM | Longitude Capital Partners IV, LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/01/2024 4:58 PM | Katabi Maha (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:52 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/30/2024 3:54 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 8:58 PM | Vera Therapeutics (Filer)
| Form S-3MEF | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Vera Therapeutics (Subject)
| Form SC 13G | |
01/29/2024 3:27 PM | Lin Celia (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 7:46 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/29/2024 5:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 5:31 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 3:54 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 8:55 PM | COMMODORE CAPITAL LP (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:17 AM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:03 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:15 AM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2024 3:15 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 8:02 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe.
Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out.
You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy...
There's also no escaping that The Big AI Die-Up is coming.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9247&Placement=NativeDisplay&Source=NativeDisplay) So go here now to read my new report The Big AI Die-Up… while you still can. |
11/09/2023 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |